85 related articles for article (PubMed ID: 21737486)
1. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodríguez-Lopez L; Castro-Serna D; Escalante-Acosta BA
Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
[TBL] [Abstract][Full Text] [Related]
2. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
[TBL] [Abstract][Full Text] [Related]
4. Preventing microalbuminuria in type 2 diabetes.
Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
[TBL] [Abstract][Full Text] [Related]
5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
6. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
Rubio-Guerra AF; Arceo-Navarro A; Vargas-Ayala G; Rodriguez-Lopez L; Lozano-Nuevo JJ; Gomez-Harper CT
Diabetes Care; 2004 Jul; 27(7):1688-91. PubMed ID: 15220247
[TBL] [Abstract][Full Text] [Related]
7. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
8. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
9. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
Fernández R; Puig JG; Rodríguez-Pérez JC; Garrido J; Redon J;
J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
[TBL] [Abstract][Full Text] [Related]
10. Trandolapril/verapamil combination in hypertensive diabetic patients.
García Donaire JA; Ruilope LM
Vasc Health Risk Manag; 2007; 3(1):77-82. PubMed ID: 17583177
[TBL] [Abstract][Full Text] [Related]
11. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
12. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
Lambertucci L; Di Serio C; Castellani S; Torrini M; Lotti E; Cristofari C; Masotti G; Marchionni N; Ungar A
Transl Res; 2011 Jun; 157(6):348-56. PubMed ID: 21575919
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
[TBL] [Abstract][Full Text] [Related]
14. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
[TBL] [Abstract][Full Text] [Related]
15. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
Kirchengast M
J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
17. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
18. Fixed combination verapamil SR/trandolapril.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
[TBL] [Abstract][Full Text] [Related]
19. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Kimura Y; Omoto S; Shouzu A; Nishikawa M; Iwasaka T
J Hum Hypertens; 2007 Jan; 21(1):38-44. PubMed ID: 17051237
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
Rosolová H; Cech F; Sefrna F
Vnitr Lek; 2002 Aug; 48(8):701-6. PubMed ID: 12425199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
